Breaking Up with Your Employer: What Physicians Need to Know About Terminating Employment Agreements

By: Michelle Caputi

Ending a physician employment agreement is a significant decision that requires careful planning and attention to detail. Whether you’re moving on to a new opportunity, stepping away from clinical practice, or simply seeking a better fit, the way you handle your termination can have lasting effects on your career, reputation, and relationships within the medical community.

Step 1: Review the Termination Provisions

The first step in terminating your physician employment agreement is to carefully review the termination provisions in your contract. These provisions outline the rules and requirements for ending the agreement, including:

· Termination for Cause vs. Without Cause: Most physician contracts allow for termination either “for cause” or “without cause.” Terminating for cause typically involves specific reasons outlined in the contract, such as misconduct or breach of duties. However, this can have serious implications for your future employment and references. Terminating without cause is often the safer route, but it’s important to consult with a healthcare attorney to determine the best approach for your situation.

· Notice Period: Many contracts require a specific notice period before termination. This could range from 30 to 120 days or more. Failing to provide proper notice could result in financial penalties or legal disputes.

Step 2: Understand the Notice Requirements

Once you’ve reviewed the termination provisions, it’s time to focus on the notice requirements. Pay close attention to:

· How to Provide Notice: Your contract may specify how notice must be given—whether it’s in writing, via certified mail, or through another method. Following these instructions to the letter is critical to ensure your termination is valid.

· Timing: Make sure you provide notice within the required timeframe. If you’re planning to terminate without cause, giving ample notice can help maintain goodwill and ensure a smoother transition.

Step 3: Check for Non-Compete Provisions

Non-compete provisions, also known as restrictive covenants, are common in physician employment agreements. These clauses may limit your ability to practice within a certain

geographic area or timeframe after leaving your current employer. Before terminating your agreement, review the non-compete language carefully to understand:

· Scope and Duration: How far does the restriction extend, and for how long? Are there exceptions for certain types of practice or locations?

· Enforceability: Non-compete clauses are subject to state laws, and their enforceability can vary widely. A healthcare attorney can help you assess whether your non-compete is likely to hold up in court.

Step 4: Evaluate Tail Coverage

Tail coverage is a critical consideration when terminating a physician employment agreement. This type of insurance provides protection against malpractice claims that arise after you leave your employer but are related to incidents that occurred during your employment. Key questions to ask include:

· Who Pays for Tail Coverage? Some contracts require the employer to cover the cost, while others place the responsibility on the physician.

· What Are the Costs? Tail coverage can be expensive, so it’s important to budget for this expense if you’re responsible for it.

Step 5: Review Indemnification Language

Indemnification clauses outline how liability is handled during your employment. Before terminating your agreement, review this language to understand:

· Your Coverage: Were you adequately protected during the course of your employment? Are there any lingering liabilities you need to address?

· Post-Termination Obligations: Does the indemnification clause impose any obligations on you after you leave?

Step 6: Consider the Impact of Termination

Terminating your employment agreement is not just a legal and financial decision—it’s also a professional and relational one. Consider the following:

· Future Employment and References: Terminating for cause can raise red flags for future employers and may impact your ability to secure positive references. Whenever possible, lean toward terminating without cause to preserve your professional reputation.

· Community Relationships: Maintaining positive relationships with facilities, medical staff, and colleagues is essential, especially if you plan to continue practicing in the same area. A respectful and professional approach to termination can go a long way in preserving these connections.

Step 7: Consult with a Healthcare Attorney

Terminating a physician employment agreement is a complex process with significant legal and professional implications. Consulting with a healthcare attorney can help you:

· Understand your rights and obligations under the contract.

· Navigate the termination process smoothly and avoid potential disputes.

· Protect your career, reputation, and financial interests.

Ending a physician employment agreement is never a decision to take lightly, but with careful planning and the right guidance, it can be a positive step forward in your career. By reviewing your contract, understanding your obligations, and seeking legal advice, you can ensure a smooth transition and set yourself up for success in your next chapter.

Florida’s CHOICE Act: A New Era for Noncompete and Garden Leave Agreements

By: Caitlin A. Koppenhaver

Effective July 1, 2025, Florida’s CHOICE Act (Contracts Honoring Opportunity, Investment, Confidentiality, and Economic Growth) significantly expands the enforceability of noncompete and garden leave agreements, making Florida one of the most employer-friendly states in the country for restrictive covenant enforcement.

Who Is Covered?
The law applies to employees and independent contractors earning more than twice the average annual wage in their Florida county of residence or the employer’s principal place of business. Healthcare practitioners are specifically excluded. Both Florida-based employers and out-of-state companies with Florida employees may fall under the Act.

Noncompete Agreements
Covered noncompete agreements can restrict a former employee from working in a similar role or using confidential information for up to four years after employment ends. To be enforceable, the agreement must be in writing, provided at least seven days before the offer to enter into an employment agreement expires, and must inform the employee of their right to seek legal counsel before execution of the agreement. The employee must also acknowledge they will have access to confidential information or customer relationships.

Garden Leave Agreements

Garden leave provisions allow an employer to require advance notice of resignation up to four yearsduring which the employee remains on payroll with full salary and benefits. The employee is only obligated to work for the first 90 days of that notice period. Similar procedural requirements apply as with noncompetes.

Enforcement
The CHOICE Act presumes these agreements are enforceable. Courts are required to issue injunctions unless the employee proves, by clear and convincing evidence, that their new role will not involve unfair competition or misuse of confidential information, or that the employer failed to uphold their payment obligations during the garden leave period.

What This Means for Employers and Employees

Employers should review and update their agreements to comply with the CHOICE Act’s requirements. Employees entering into these agreements should understand the legal obligations they are assuming, as these restrictions may significantly impact future employment opportunities.

Florida Health Care Providers: Don’t Miss the New Background Check Rule Starting July 1, 2025

By: Caitlin A. Koppenhaver

“Cleared to Care” Campaign Helps You Stay Compliant and Licensed

If you’re a licensed health care provider in Florida, there’s a big change coming your way. Florida’s House Bill 975 (HB 975), which became law effective July 1st, 2025 requires most licensed providers to complete a background screening when applying for or renewing their individual licensure. Staying compliant with the new law is mandatory to maintain licensure. To help licensed providers comply and prepare, the state has launched a “Cleared to Care” campaign.

Who Needs to Do This?

Most licensed health care professionals in Florida will be affected, including doctors, nurses, therapists, and more. However, there are a few exemptions. Emergency medical technicians, paramedics, pharmacy interns, registered pharmacy technicians, and radiologic technicians are exempt unless applying through the military active-duty spouse licensure pathway. Fingerprint retention requirements do not apply to these professions. 

What You Need to Know

This isn’t just a routine update. If you delay the screening process, your license application or renewal could be delayed or expired. Because fingerprinting and processing may take time, especially since this has become a requirement for most licensed healthcare professions, it’s important to complete this step as soon as possible.

For License Renewals

You can start renewing 90 days before your license expires. It’s best to get your fingerprinting completed as soon as possible to avoid delays in obtaining or renewing your Florida license.

For New Applicants

You must complete the background screening as part of your application. Don’t wait until the last minute. There are also resources for out-of-state applicants to complete this step.

Act Now, Don’t Risk Losing Your License

With thousands of practitioners needing to comply, waiting until the last minute is risky. Start your background screening early to avoid delays or interruptions in your ability to practice. 

Additional Resources:

Florida’s Cleared to Care Campaign: 205.03.25-ClearedtoCare-Poster.pdf

Background Screening Steps and FAQ: Initiate a Screening – FL HealthSource • Health Care Resources for Consumers & Providers

Florida Healthcare Law Firm Announces Shareholder Promotion

Carlos H. Arce

Delray Beach, FL – The Florida Healthcare Law Firm, established in 2008 by Florida Board Certified Health Law Attorney Jeff Cohen, is proud to announce the promotion of Carlos H. Arce to shareholder. This significant milestone marks a new chapter in the firm’s growth, reinforcing its commitment to excellence, leadership, and long-term succession planning.

With a strong foundation built on specialized expertise in healthcare law, the Florida Healthcare Law Firm has become a trusted name for healthcare professionals and healthcare businesses seeking legal strategy and guidance. The addition of shareholder Carlos H. Arce, Esq. further solidifies the firm’s leadership and ensures its continuity in providing exceptional service to clients.

Founder Jeff Cohen shared his confidence in the firm’s future, stating, “I wanted to be able to show and say that I’m confident in the firm’s succession from this point on. This promotion highlights the strength of our team and the bright path Carlos has ahead of him.”

Mr. Arce has been integral to the firm’s success, bringing unique expertise, dedication, and a client-first approach to his work. His advancement to shareholder not only reflects his professional excellence but also his commitment to upholding the firm’s values and vision.

The Florida Healthcare Law Firm looks forward to continuing its tradition of delivering unparalleled legal support to clients across the healthcare industry, now with an even stronger leadership team.

Regen Consent if FL Law Passes

Front View Doctor With Surgical Gloves Holding Vaccine Syringe

Credit: Caitlin A. Koppenhaver

A significant legal change in Florida is on the horizon that could directly impact providers and practices offer stem cell therapies. Beginning July 1, 2025, Florida’s House Bill 1617 (2025) goes into effect, allowing certain licensed healthcare professionals to administer stem cell treatments, but only under strict conditions. With these new allowances come clear responsibilities, especially when it comes to patient notification and informed consent. Now is the time to ensure your documentation and protocols are up to date to stay compliant and protect your practice.

House Bill 1617 (2025) authorizes certain licensed physicians in Florida (Specifically Chapters 458 and 459, therefore this includes Ch.458- MD’s, and Ch. 459, DO’s) to perform stem cell therapies that have not been approved by the United States Food and Drug Administration (FDA), but only under limited and defined circumstances. These therapies may only be administered when they fall within the provider’s scope of practice and are specifically related to orthopedics, wound care, or pain management. The legislation imposes clear limitations on the types of stem cells permitted, expressly excluding fetal-derived cells, embryonic tissue from abortions, and adipose-derived mesenchymal stem cells (stem cells from fat tissue).

All stem cells used under this statute must be manufactured in FDA-certified clean room environments that utilize high-efficiency air filtration systems to reduce the risk of contamination. Additionally, the retrieval, processing, and storage of these stem cells must take place in facilities that are both FDA-registered and accredited by recognized organizations such as the National Marrow Donor Program or the American Association of Tissue Banks, among others that the statute lists.

The bill mandates strict patient notification and informed consent procedures. Health care providers must deliver a written notice to patients, in a specific font and size, and clearly displayed in the provider’s office, advising that the stem cell therapies being offered are not FDA-approved. The bill includes specific verbiage for this notice:

(4) A health care provider who conducts stem cell therapy pursuant to this section shall provide a patient who is being treated with stem cell therapy with the following written notice before performing the therapy: 

“THIS NOTICE MUST BE PROVIDED TO YOU UNDER FLORIDA LAW. This health care practitioner performs one or more stem cell therapies that have not yet been approved by the United States Food and Drug Administration. You are encouraged to consult with your primary care provider before undergoing any stem cell therapy.”

Important: This notice must also be included in any advertisement for the stem cell therapy. In any form of advertisement, the notice must be clearly legible and in a font size no smaller than the largest font size used in the advertisement.

Prior to the provider performing stem cell therapy, treatment, providers are required to obtain a consent form signed by the patient. The consent form must include: 

1. The nature and character of the proposed treatment, including the treatment’s United States Food and Drug Administration approval status.

2. The anticipated results of the proposed treatment.

3. The recognized possible alternative forms of treatment.

4. The recognized serious possible risks, complications, and anticipated benefits involved in the treatment and in the recognized possible alternative forms of treatment, including nontreatment.

The legislation exempts providers engaged in FDA-approved investigational drug or device trials and those operating under contract with accredited institutions recognized for their expertise in stem cell therapy. Any violation of the statute may result in disciplinary action by the relevant regulatory board or agency. The Department of Health is responsible for adopting rules to implement this law, which takes effect on July 1, 2025.

As we approach the July 1 effective date, it’s important to take a proactive approach. Updating your informed consent forms, office signage, and any related advertising isn’t just a legal requirement—it’s an opportunity to reinforce patient trust and uphold ethical standards in your care. Making these changes now will help you avoid regulatory issues down the line and ensure you’re ready to responsibly offer these advanced therapies within the scope of the new law.

New Regulations on Retail IV Therapy Clinics in Ohio

IV Therapy

Credit: Caitlin Koppenhaver

The State Medical Board of Ohio, the Ohio Board of Pharmacy (BOP), and the Ohio Board of Nursing have issued a joint statement that significantly impacts the operation of retail IV therapy clinics across the state. These new guidelines are designed to ensure safety, proper oversight, and compliance within these clinics, affecting both providers and patients.

Here’s what you need to know about the new regulatory measures:

Who Can Diagnose, Treat, or Prescribe IV Medications in Ohio?

Under the new rules, only the following licensed professionals are authorized to diagnose, treat, or prescribe IV medications in Ohio:

1. Physicians licensed under Chapter 4731 of the Ohio Revised Code.

2. Physician Assistants (PAs) who hold:

o A valid prescriber number issued by the State Medical Board of Ohio.

o Physician-delegated prescriptive authority specific to this purpose.

3. Advanced Practice Registered Nurses (APRNs), including:

o Certified Nurse Practitioners (CNPs)

o Certified Nurse Midwives (CNMs)

o Clinical Nurse Specialists (CNSs)

o Licensed under Chapter 4723 of the Ohio Revised Code.

This restricts the ability of any other healthcare personnel, such as nurses or paramedics, from independently ordering or administering IV therapy without direct authorization from an above-listed prescriber.

Standing Orders Prohibited for IV Therapy Administration

A critical change in these regulations is the explicit prohibition of standing orders (or protocols) for the recommendation, compounding, and administration of IV medications. This means that:

· Nurses, paramedics, or other non-prescribing staff may not use protocols to initiate IV therapy services in retail clinics.

· All IV treatments must be based on an individualized diagnosis and prescription from an authorized prescriber.

Exceptions for Protocol Use

Protocols for drug administration are only allowable under highly specific circumstances, such as:

1. Emergency Situations

For instance, in cases of acute conditions such as heart attacks, overdoses, severe burns, or other emergencies where immediate attention is critical to prevent severe harm or loss of life.

2. Disease Prevention

The administration of vaccines or biologicals to prevent diseases falls under this category, such as administering flu shots.

3. Specific Preventive Treatments

Limited to:

– Vitamin K administration in newborns to prevent vitamin K deficiency bleeding.

– Erythromycin administration for the prevention of ophthalmia neonatorum.

– Influenza antiviral treatments, particularly in institutional facilities.

These scenarios are exceptions rather than the norm and require careful adherence to Ohio’s Administrative Code (OAC 4729).

Why Are These Changes Significant?

These guidelines serve as a response to the growing trend of retail IV therapy clinics offering hydration and wellness treatments, often in non-medical settings. While these services have surged in popularity, the updated rules aim to ensure patient safety and prevent improper or unauthorized care practices.

Key concerns addressed include:

· Medical Oversight

The new rules ensure that IV therapy recommendations and administration are under the supervision of qualified prescribers.

· Patient Safety

Preventing the misuse of protocols minimizes risks associated with emergent or unsupervised medical treatments.

What This Means for Retail IV Therapy Clinics

Clinic operators and staff must review these regulatory requirements and ensure compliance, including:

· Ensuring all IV services are supervised or prescribed by licensed professionals listed in the guidelines.

· Discontinuing any standing orders or protocols currently in use for non-emergency or non-preventive services.

· Reviewing hiring practices to ensure compliance with the new rules regarding authorized prescribers.

Non-compliance may lead to regulatory action, including penalties, licensing issues, or potential closures.

Compounding Medications

The joint statement further emphasizes the definition of “compounding”, which under Ohio law is “the preparation, mixing, assembling, packaging, and labeling of one or more drugs pursuant to a prescription issued by a licensed health professional authorized to prescribe drugs. Compounding may only be performed by a licensed pharmacist or licensed health professional authorized to prescribe drugs. The preparation of IV cocktails as previously described is considered compounding under Ohio law and the clinic is required to obtain a license as a terminal distributor of dangerous drugs (TDDD) from the Ohio Board of Pharmacy.”

Final Thoughts

The joint regulatory statement emphasizes patient safety and proper medical oversight in the fast-growing field of retail IV therapy clinics. While these changes may introduce additional operational responsibilities for clinics, they ultimately align with the overarching goal of delivering safe and effective care.

For a deeper understanding of the regulations, be sure to review the full joint statement issued by the State Medical Board of Ohio, Ohio BOP, and Ohio Board of Nursing. It’s critical for clinic operators, healthcare staff, and prescribers to stay informed and adapt to these new requirements.

Navigating Dental Practice Mergers: A Comprehensive Guide for Growth and Success

Dental practice mergers

Dental practice mergers are reshaping the industry, offering dentists a strategic path to growth, efficiency, and retirement planning. By combining resources, practices can reduce costs, expand patient bases, and adopt cutting-edge technologies, achieving profit margins up to 70%. However, success hinges on navigating challenges like due diligence, cultural integration, and regulatory compliance. This guide provides a step-by-step roadmap—from identifying opportunities to transparent communication—empowering dentists to execute seamless mergers and thrive in a competitive market.

Continue reading

Autonomous Nurses: The Future of Healthcare Delivery

Autonomous nurses

Autonomous nurses, driven by AI and robotics, are transforming healthcare by addressing nursing shortages and improving patient care. This blog explores their capabilities, benefits, challenges, and ethical considerations, envisioning their role in the future of healthcare delivery.

Continue reading

Florida’s Proposed Law on Stem Cell Treatments for Orthopedic, Wound Care, and Pain Management

lawyer filling document

Credit: Jeff Cohen

Stem cell treatments have long been a topic of debate within the medical and regulatory fields, balancing potential breakthroughs in medicine with questions of safety, ethics, and oversight. A recent proposal in Florida, brought forth through a Committee Substitute for House Bill 1617, has reignited that debate by challenging existing FDA guidelines and seeking to carve a pathway for expanded use of stem cells in specific medical practices.

The Core Elements of the Proposed Law

If passed, the proposed legislation would authorize the use of stem cells in treatments for orthopedics, wound care, and pain management. While the suggested changes are ambitious, the bill also sets out clear boundaries and regulatory requirements to ensure compliance. Here’s what it entails:

Physician-Only Administration

Under the proposed law, only licensed physicians would be legally permitted to administer stem cells for treatment. This stipulation underscores a commitment to safety, requiring a level of expertise and accountability in the administration process.

Ethically-Sourced Stem Cells

The bill specifically prohibits the use of stem cells derived from embryos or fetuses following abortion. This measure is likely intended to address ethical concerns and align with public sentiment while ensuring that the law focuses on stem cells obtained through acceptable and legally compliant methods.

Stringent Manufacturing Standards

Any stem cells used under the proposed law would need to comply with precise manufacturing standards. While the bill does not describe these standards in detail, one can assume they would mirror or even surpass current regulatory best practices to ensure safety and efficacy.

Patient Notice Requirements

One of the more unique aspects of the bill is its requirement for specific written notice to be provided to patients ahead of any stem cell treatment. Notably, this same disclosure must also appear in advertisements. This transparency-first approach likely aims to inform patients about the experimental nature of the treatments and to clarify that they have not been authorized by the FDA.

What sets this bill apart is its bold acknowledgment that the use of stem cells would be permissible under Florida law even though the FDA does not currently authorize it. Typically, state-level legislation aligns with federal guidelines to avoid potential conflicts, particularly where health and safety regulations are concerned. However, House Bill 1617 represents a significant departure by prioritizing patient choice over federal consent.

This raises important legal questions about the relationship between state and federal oversight in medical treatments. Can (or should) individual states legislate to expand patient access to emerging therapies when federal health authorities have not yet sanctioned their use?

Florida’s proposed law follows a growing trend in the United States to expand patient access to alternative and innovative therapies, particularly in cases where traditional treatment methods have been insufficient. The widely discussed “Right to Try” laws, for example, have given terminally ill patients greater access to experimental drugs not yet approved by the FDA.

House Bill 1617 represents an extension of this broader movement by addressing treatments with stem cells for specific conditions. However, the legislation also comes with inherent risks. Without FDA authorization, there may be questions about the long-term safety and efficacy of these treatments, as well as the quality control of stem cell manufacturing.

Florida has an interesting history when it comes to regulating stem cell use in medicine. It wasn’t so long ago—in 2013, to be exact—that the Florida Board of Medicine took the significant step of revoking the licenses of two physicians who were involved in using stem cells for patient treatments outside established regulations. This history demonstrates the fine line lawmakers must walk in balancing innovation with regulatory oversight to protect patient welfare.

If passed, House Bill 1617 would represent a major shift not only for Florida but potentially for the wider conversation on stem cell treatment in the United States. By directly challenging FDA policy and expanding patient access to stem cell therapies within a regulated framework, it could set a precedent for other states to follow suit. However, the bill must first withstand significant legislative and legal hurdles before it can become law.

Florida’s proposed stem cell law has the potential to open new doors for medical treatments, giving patients more choices while pushing regulatory boundaries. Despite its ambition, though, the bill’s complexity and conflict with federal guidelines mean there’s a long road ahead. The key to its success—or failure—will likely lie in its ability to balance the innovative use of stem cells with a strong commitment to safety, ethics, and long-term outcomes.

For now, it remains a waiting game. But the implications of this proposal, both for Florida and for the broader field of medical innovation, are impossible to ignore.

Medical Practice Compliance Plan: A Step-by-Step Guide to Avoiding Penalties and Protecting Patients

Medical practice compliance plan

In today’s complex healthcare landscape, medical practices face ever-evolving regulations. From HIPAA to OSHA, Medicare billing rules to anti-kickback laws, compliance is no longer optional—it’s a necessity. A medical practice compliance plan isn’t just about avoiding fines; it’s about fostering trust, improving patient care, and safeguarding your practice’s reputation.

This guide will break down what a compliance plan entails, why it matters, and how to create one tailored to your practice. Whether you’re a small clinic or a multi-specialty group, these actionable steps will help you stay on the right side of the law.

Why Your Medical Practice Needs a Compliance Plan

  1. Avoid Costly Penalties
    Non-compliance can lead to staggering fines. For example:
    • HIPAA violations range from 100 to 50,000 per record breached.
    • Medicare fraud penalties can exceed $10,000 per claim.
    • OSHA fines for workplace safety issues often exceed $15,000 per violation.
  2. Protect Patient Trust
    Patients expect their data and safety to be prioritized. A breach or lawsuit erodes confidence and can drive patients to competitors.
  3. Streamline Operations
    Compliance plans standardize processes, reducing errors in billing, documentation, and patient care.
  4. Meet Legal Requirements
    The Affordable Care Act (ACA) mandates compliance programs for Medicare/Medicaid providers. Even if not required, having one demonstrates “due diligence” in audits.

7 Key Components of an Effective Medical Practice Compliance Plan

The Office of Inspector General (OIG) outlines seven core elements for compliance programs. Let’s simplify them:

1. Written Policies and Procedures

  • What to Include:
    • HIPAA privacy and security protocols.
    • Billing and coding guidelines (e.g., CPT, ICD-10 accuracy).
    • OSHA safety standards (e.g., handling hazardous materials).
    • Anti-fraud policies (e.g., Stark Law, Anti-Kickback Statute).
  • Tip: Update policies annually or when laws change.

2. Compliance Officer and Committee

  • Compliance Officer Role:
    • Oversee program implementation.
    • Investigate suspected violations.
    • Train staff on regulations.
  • Committee Members: Include physicians, administrators, and IT/HR reps.

3. Staff Training and Education

  • Mandatory Topics:
    • HIPAA (e.g., phishing scams, password security).
    • Proper documentation (avoiding “upcoding”).
    • Sexual harassment prevention.
  • Frequency: Train new hires and conduct annual refreshers.

4. Open Communication Channels

  • Whistleblower Protections: Ensure staff can report issues anonymously without retaliation.
  • Example: Set up a hotline or encrypted email for concerns.

5. Internal Monitoring and Auditing

  • Conduct Regular Audits:
    • Review 5-10% of Medicare/Medicaid claims monthly.
    • Check EHR access logs for unauthorized entries.
    • Inspect OSHA compliance (e.g., fire exits, PPE supplies).
  • Use Audit Tools: CMS’s Risk Assessment Toolkit or third-party software.

6. Enforcement and Discipline

  • Consistent Penalties: Apply fair consequences for violations (e.g., retraining, suspension).
  • Document Actions: Prove accountability in case of audits.

7. Corrective Action Plans

  • Respond to Issues: If a breach occurs, act swiftly to:
    • Mitigate harm (e.g., notify patients of data breaches within 60 days).
    • Update policies to prevent recurrence.

Step-by-Step Guide to Building Your Compliance Plan

Step 1: Conduct a Risk Assessment

  • Identify vulnerabilities (e.g., outdated software, untrained staff).
  • Prioritize high-risk areas like billing and data security.

Step 2: Draft Policies

  • Use OIG or CMS templates to save time.
  • Customize for your specialty (e.g., mental health vs. surgery).

Step 3: Train Your Team

  • Host interactive workshops with quizzes.
  • Use real-world examples (e.g., “Is this email a HIPAA violation?”).

Step 4: Implement Monitoring Tools

  • Use software like HIPAA Secure Now for automated audits.
  • Schedule quarterly walkthroughs for OSHA compliance.

Step 5: Review and Revise

  • Analyze audit results and update policies.
  • Stay informed about regulatory changes via HHS or CMS newsletters.

Also Read: Licensed for Care, not Commerce: Ethical Excellence in Healthcare

Common Compliance Pitfalls (and How to Avoid Them)

  1. Coding Errors
    • Problem: Upcoding (billing for a higher-paying service than performed).
    • Fix: Use AI-powered coding tools like AAPC’s Codify.
  2. Poor Document Management
    • Problem: Losing patient records or failing to secure them.
    • Fix: Store files in HIPAA-compliant cloud systems like Dropbox Health.
  3. Ignoring OSHA
    • Problem: Failing to provide hepatitis B vaccines to at-risk staff.
    • Fix: Partner with occupational health clinics for compliance.
  4. Inadequate Training
    • Problem: Assuming staff “know the rules.”
    • Fix: Require signed training acknowledgments.

FAQs About Medical Practice Compliance Plans

Q: How much does a compliance plan cost?

  • A: Costs vary. Small practices spend 2,000−2,000−5,000 annually on software/training.

Q: Can I use a template?

  • A: Yes! CMS offers free templates, but customize them for your practice.

Q: What’s the #1 mistake practices make?

  • A: Failing to document compliance efforts. If it’s not written down, it didn’t happen.

Conclusion

A medical practice compliance plan isn’t a luxury—it’s a lifeline. By investing in clear policies, ongoing training, and proactive monitoring, you protect your practice from legal nightmares while delivering safer, higher-quality care. Start small: appoint a compliance officer, conduct a risk assessment, and build from there.

Need Help? Consult healthcare attorneys or compliance firms like Compliancy Group to ensure your plan meets all federal and state requirements.

Also Read: Healthcare Marketing Update for Sellers of Weight Loss Medications